Catabasis Pharmaceuticals, Inc. CATB
Trading inactive
Finances
| 2024 | |
|---|---|
| Revenue | 0.000 |
| Net income | -94.260 M |
| Income before tax | -94.260 M |
| Income before tax ratio | 0.00 |
| EBITDA | -111.558 M |
| Net income ratio | 0.00 |
| Ratio EBITDA | 0.00 |
| Gross profit ratio | 0.00 |
| Weighted average shs out dil | 0.000 |
| Weighted average shs out | 0.000 |
| EPS diluted | -1.68 |
| Earnings per share | -1.68 |
| Gross profit | 0.000 |
| Income tax expense | 0.000 |
| Cost of revenue | 0.000 |
| General and administrative expenses | 34.452 M |
| Selling and marketing expenses | 0.000 |
| Other expenses | 0.000 |
| Operating expenses | 111.558 M |
| Cost and expenses | 0.000 |
| Research and development expenses | 77.106 M |
| Selling general and administrative expenses | 34.452 M |
| Interest income | 17.360 M |
| Interest expense | 0.000 |
| Depreciation and amortization | 0.000 |
| Operating income | -111.558 M |
| Operating income ratio | 0.00 |
| Total other income expenses net | 17.298 M |
| 2024 |
| 2024 | |
|---|---|
| Net debt | -54.467 M |
| Total investments | 268.312 M |
| Total debt | 5.353 M |
| Accumulated other comprehensive income loss | 0.000 |
| Retained earnings | -674.794 M |
| Common stock | 57.000 K |
| Total equity | 0.000 |
| Other non current liabilities | 0.000 |
| Long term debt | 3.969 M |
| Total non current liabilities | 3.969 M |
| Other current liabilities | 13.427 M |
| Deferred revenue | 0.000 |
| Short term debt | 1.384 M |
| Total current liabilities | 19.131 M |
| Total liabilities | 23.100 M |
| Other non current assets | 2.606 M |
| Long term investments | 0.000 |
| Intangible assets | 0.000 |
| GoodWill | 0.000 |
| Goodwill and intangible assets | 0.000 |
| Property plant equipment net | 5.114 M |
| Total non current assets | 7.720 M |
| Other current assets | 6.511 M |
| Short term investments | 268.312 M |
| cash and cash equivalents | 59.820 M |
| Cash and short term investments | 328.132 M |
| Total current assets | 334.643 M |
| Inventory | 0.000 |
| Net receivables | 0.000 |
| Tax assets | 0.000 |
| Other assets | 0.000 |
| Account payables | 4.320 M |
| Tax payables | 0.000 |
| Deferred revenue non current | 0.000 |
| Minority interest | 0.000 |
| Capital lease obligations | 0.000 |
| Preferred stock | 95.324 M |
| Other total stockholders equity | 994.000 M |
| Deferred tax liabilities non current | 0.000 |
| Other liabilities | 0.000 |
| Total assets | 342.363 M |
| 2024 |
| 2024 | |
|---|---|
| Deferred income tax | 0.000 |
| Stock based compensation | 13.042 M |
| Change in working capital | 0.000 |
| Accounts receivables | 0.000 |
| Inventory | 0.000 |
| Accounts payables | 2.807 M |
| Other working capital | 0.000 |
| Other non cash items | 6.000 K |
| Net cash provided by operating activities | -81.212 M |
| Investments in property plant and equipment | -325.000 K |
| Acquisitions net | 0.000 |
| Purchases of investments | -4.245 B |
| Sales maturities of investments | 4.053 B |
| Other investing activites | 0.000 |
| Net cash used for investing activites | -191.863 M |
| Debt repayment | 0.000 |
| Common stock issued | 0.000 |
| Common stock repurchased | 0.000 |
| Dividends paid | 0.000 |
| Other financing activites | 157.202 M |
| Net cash used provided by financing activities | 157.202 M |
| Effect of forex changes on cash | 0.000 |
| Net change in cash | -115.873 M |
| Cash at beginning of period | 175.693 M |
| Cash at end of period | 59.820 M |
| Operating cash flow | -81.212 M |
| Capital expenditure | -325.000 K |
| Free CashFlow | -81.537 M |
| 2024 |
| 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|
| Revenue | 706.000 K | 0.000 | 0.000 |
| Net income | -31.643 M 4.26 % | -33.052 M 1.95 % | -33.709 M |
| Income before tax | -31.643 M 4.26 % | -33.052 M 1.95 % | -33.709 M |
| Income before tax ratio | -44.82 | 0.00 | 0.00 |
| EBITDA | -31.643 M 11.66 % | -35.820 M 3.18 % | -36.995 M |
| Net income ratio | -44.82 | 0.00 | 0.00 |
| Ratio EBITDA | -44.82 | 0.00 | 0.00 |
| Gross profit ratio | 0.00 | 0.00 | 0.00 |
| Weighted average shs out dil | 0.000 | 0.000 | 0.000 |
| Weighted average shs out | 0.000 | 0.000 | 0.000 |
| EPS diluted | -0.55 3.51 % | -0.57 1.72 % | -0.58 |
| Earnings per share | -0.55 3.51 % | -0.57 1.72 % | -0.58 |
| Gross profit | 0.000 | 0.000 | 0.000 |
| Income tax expense | 0.000 | 0.000 | 0.000 |
| Cost of revenue | 0.000 | 0.000 | 0.000 |
| General and administrative expenses | 10.661 M 7.96 % | 9.875 M 7.23 % | 9.209 M |
| Selling and marketing expenses | 0.000 | 0.000 | 0.000 |
| Other expenses | 0.000 | 0.000 | 0.000 |
| Operating expenses | 34.810 M -2.82 % | 35.820 M -3.18 % | 36.995 M |
| Cost and expenses | 34.810 M | 0.000 | 0.000 |
| Research and development expenses | 24.149 M -6.92 % | 25.945 M -6.63 % | 27.786 M |
| Selling general and administrative expenses | 10.661 M 7.96 % | 9.875 M 7.23 % | 9.209 M |
| Interest income | 2.498 M -13.53 % | 2.889 M -13.66 % | 3.346 M |
| Interest expense | 0.000 | 0.000 | 0.000 |
| Depreciation and amortization | 0.000 | 0.000 | 0.000 |
| Operating income | -34.104 M 4.79 % | -35.820 M 3.18 % | -36.995 M |
| Operating income ratio | -48.31 | 0.00 | 0.00 |
| Total other income expenses net | 2.461 M -11.09 % | 2.768 M -15.76 % | 3.286 M |
| 2025-09-30 | 2025-06-30 | 2025-03-31 |
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | |
|---|---|---|---|---|
| Net debt | -91.821 M -28.33 % | -71.553 M -45.07 % | -49.322 M 9.45 % | -54.467 M |
| Total investments | 0.000 -100.00 % | 182.859 M -24.02 % | 240.679 M -10.30 % | 268.312 M |
| Total debt | 4.459 M -6.44 % | 4.766 M -5.87 % | 5.063 M -5.42 % | 5.353 M |
| Accumulated other comprehensive income loss | 0.000 100.00 % | -16.000 K | 0.000 | 0.000 |
| Retained earnings | -773.198 M -4.27 % | -741.555 M -4.67 % | -708.503 M -5.00 % | -674.794 M |
| Common stock | 57.000 K 0.00 % | 57.000 K 0.00 % | 57.000 K 0.00 % | 57.000 K |
| Total equity | 233.253 M -10.46 % | 260.513 M | 0.000 -100.00 % | 319.263 M |
| Other non current liabilities | 12.041 M | 0.000 | 0.000 | 0.000 |
| Long term debt | 3.055 M -9.27 % | 3.367 M -8.28 % | 3.671 M -7.51 % | 3.969 M |
| Total non current liabilities | 15.096 M 348.35 % | 3.367 M -8.28 % | 3.671 M -7.51 % | 3.969 M |
| Other current liabilities | 16.481 M 3.61 % | 15.907 M 28.92 % | 12.339 M -8.10 % | 13.427 M |
| Deferred revenue | 4.495 M | 0.000 | 0.000 | 0.000 |
| Short term debt | 1.404 M 0.36 % | 1.399 M 0.50 % | 1.392 M 0.58 % | 1.384 M |
| Total current liabilities | 23.517 M 30.33 % | 18.044 M 3.55 % | 17.426 M -8.91 % | 19.131 M |
| Total liabilities | 38.613 M 80.34 % | 21.411 M 1.49 % | 21.097 M -8.67 % | 23.100 M |
| Other non current assets | 14.066 M 59.99 % | 8.792 M 239.98 % | 2.586 M -0.77 % | 2.606 M |
| Long term investments | 0.000 | 0.000 | 0.000 | 0.000 |
| Intangible assets | 0.000 | 0.000 | 0.000 | 0.000 |
| GoodWill | 0.000 | 0.000 | 0.000 | 0.000 |
| Goodwill and intangible assets | 0.000 | 0.000 | 0.000 | 0.000 |
| Property plant equipment net | 4.254 M -6.42 % | 4.546 M -5.94 % | 4.833 M -5.49 % | 5.114 M |
| Total non current assets | 18.320 M 37.35 % | 13.338 M 79.78 % | 7.419 M -3.90 % | 7.720 M |
| Other current assets | 8.582 M -8.78 % | 9.408 M 19.03 % | 7.904 M 21.39 % | 6.511 M |
| Short term investments | 131.441 M -28.12 % | 182.859 M -24.02 % | 240.679 M -10.30 % | 268.312 M |
| cash and cash equivalents | 96.280 M 26.15 % | 76.319 M 40.33 % | 54.385 M -9.09 % | 59.820 M |
| Cash and short term investments | 227.721 M -12.14 % | 259.178 M -12.16 % | 295.064 M -10.08 % | 328.132 M |
| Total current assets | 253.546 M -5.60 % | 268.586 M -11.35 % | 302.968 M -9.47 % | 334.643 M |
| Inventory | 0.000 | 0.000 | 0.000 | 0.000 |
| Net receivables | 17.243 M | 0.000 | 0.000 | 0.000 |
| Tax assets | 0.000 | 0.000 | 0.000 | 0.000 |
| Other assets | 0.000 | 0.000 | 0.000 | 0.000 |
| Account payables | 1.137 M 54.07 % | 738.000 K -80.03 % | 3.695 M -14.47 % | 4.320 M |
| Tax payables | 0.000 | 0.000 | 0.000 | 0.000 |
| Deferred revenue non current | 0.000 | 0.000 | 0.000 | 0.000 |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 |
| Capital lease obligations | 0.000 | 0.000 | 0.000 | 0.000 |
| Preferred stock | 95.324 M 0.00 % | 95.324 M 0.00 % | 95.324 M 0.00 % | 95.324 M |
| Other total stockholders equity | 1.006 B 0.44 % | 1.002 B 0.43 % | 997.736 M 0.38 % | 994.000 M |
| Deferred tax liabilities non current | 0.000 | 0.000 | 0.000 | 0.000 |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 |
| Total assets | 271.866 M -3.57 % | 281.924 M -9.17 % | 310.387 M -9.34 % | 342.363 M |
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|
| Deferred income tax | 0.000 | 0.000 | 0.000 |
| Stock based compensation | 4.308 M -0.99 % | 4.351 M 13.34 % | 3.839 M |
| Change in working capital | 0.000 | 0.000 | 0.000 |
| Accounts receivables | -17.243 M | 0.000 | 0.000 |
| Inventory | 0.000 | 0.000 | 0.000 |
| Accounts payables | 398.000 K 113.46 % | -2.957 M -373.12 % | -625.000 K |
| Other working capital | 0.000 | 0.000 | 0.000 |
| Other non cash items | -4.196 M 23.23 % | -5.466 M -31.77 % | -4.148 M |
| Net cash provided by operating activities | -32.295 M 10.44 % | -36.058 M -6.00 % | -34.018 M |
| Investments in property plant and equipment | 0.000 100.00 % | -590.000 K | 0.000 |
| Acquisitions net | 0.000 | 0.000 | 0.000 |
| Purchases of investments | -69.747 M 88.15 % | -588.418 M 21.69 % | -751.417 M |
| Sales maturities of investments | 122.000 M -81.14 % | 647.000 M -17.05 % | 780.000 M |
| Other investing activites | 0.000 | 0.000 | 0.000 |
| Net cash used for investing activites | 52.253 M -9.90 % | 57.992 M 102.89 % | 28.583 M |
| Debt repayment | 0.000 | 0.000 | 0.000 |
| Common stock issued | 0.000 | 0.000 | 0.000 |
| Common stock repurchased | 0.000 | 0.000 | 0.000 |
| Dividends paid | 0.000 | 0.000 | 0.000 |
| Other financing activites | 3.000 K | 0.000 | 0.000 |
| Net cash used provided by financing activities | 3.000 K | 0.000 | 0.000 |
| Effect of forex changes on cash | 0.000 | 0.000 | 0.000 |
| Net change in cash | 19.961 M -9.00 % | 21.934 M 503.57 % | -5.435 M |
| Cash at beginning of period | 76.319 M 40.33 % | 54.385 M -9.09 % | 59.820 M |
| Cash at end of period | 96.280 M 26.15 % | 76.319 M 40.33 % | 54.385 M |
| Operating cash flow | -32.295 M 10.44 % | -36.058 M -6.00 % | -34.018 M |
| Capital expenditure | 0.000 100.00 % | -590.000 K | 0.000 |
| Free CashFlow | -32.295 M 11.88 % | -36.648 M -7.73 % | -34.018 M |
| 2025 | 2025 | 2025 |